{"id":"W4379522672","doi":"10.1136/annrheumdis-2023-eular.2374","title":"POS0250 PLACEBO-CONTROLLED EFFICACY AND SAFETY OF UPADACITINIB THROUGH ONE YEAR IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Gilead Sciences; Pfizer; Celltrion; Eli Lilly and Company; Amgen","keywords":"Medicine; Placebo; Axial spondyloarthritis; Radiography; Internal medicine; Nuclear medicine; Radiology; Ankylosing spondylitis; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001451464,0.0009051067,0.002023094,0.0003636988,0.0003900678,0.0009936653,0.0005572798,0.001122585,0.005744108],"category_scores_gemma":[0.001535139,0.0004059873,0.002367957,0.0004475123,0.0006987486,0.001547007,0.0003340658,0.002661853,0.001041439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005744373,"about_ca_system_score_gemma":0.0006407461,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008765691,"about_ca_topic_score_gemma":0.0017595,"domain_scores_codex":[0.9993006,0.000266997,0.00006435487,0.0001483297,0.00004896327,0.0001707977],"domain_scores_gemma":[0.9992488,0.0001862119,0.000212127,0.00008447321,0.00007994362,0.0001883689],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9537919,0.004397328,0.00273612,0.0004753865,0.001337453,0.00009513044,0.00004740566,0.0004744684,0.005032391,0.0001093644,0.001100025,0.030403],"study_design_scores_gemma":[0.5283868,0.3909703,0.06751592,0.0002096645,0.003730489,0.0004200152,0.0001734793,0.001593073,0.003246182,0.0003773493,0.00329174,0.00008498091],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897741,0.005742208,0.0002327332,0.0002837553,0.0002813163,0.0002655384,0.001326967,0.00007527419,0.002018092],"genre_scores_gemma":[0.99563,0.001245729,0.0001520188,0.0003029391,0.000126072,0.0001703297,0.001253128,0.000008712818,0.001111066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005744108,"threshold_uncertainty_score":0.01921594,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01849263614503937,"score_gpt":0.2666985424464458,"score_spread":0.2482059063014064,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}